Ticker

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report) was the target of a significant growth in short interest in February. As of February 27th, there was short interest totaling 55,704 shares, a growth of 163.7% from the February 12th total of 21,126 shares. Based on an average daily trading volume, of 224,823 shares, the

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report) saw a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 21,126 shares, a drop of 67.6% from the January 29th total of 65,207 shares. Approximately 0.9% of the shares of the company are short sold.

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report)'s stock price dropped 5.3% on Friday. The company traded as low as $0.21 and last traded at $0.2130. Approximately 93,300 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 183,739 shares. The stock had previously closed at $0.2250.

Virax Biolabs Group Limited (VRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).